Taichung, Taiwan

Shih-Wen Li

This inventor holds 1 USPTO granted patent. Top assignee: China Medical University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shih-Wen Li. Retrieved from https://idiyas.com/inventor/shih-wen-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Shih-Wen Li in Virus Treatment

Introduction

Shih-Wen Li is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of viral infections. His innovative approach has led to the development of a unique method that utilizes derivatives of aniline.

Latest Patents

Shih-Wen Li holds 1 patent for his invention titled "Method for treating virus infection using derivative of aniline." This patent describes a method for treating a virus infection in a subject by administering an effective amount of a derivative of aniline. The derivatives include a compound of formula (I), its pharmaceutically acceptable salts, esters, and combinations thereof.

Career Highlights

Li is affiliated with China Medical University, where he continues to engage in research and development. His work focuses on innovative solutions to combat viral infections, showcasing his commitment to advancing medical science.

Collaborations

Shih-Wen Li collaborates with esteemed colleagues, including Cheng-Wen Lin and An-Cheng Huang. Their combined expertise enhances the research efforts at China Medical University.

Conclusion

Shih-Wen Li's contributions to the treatment of viral infections through his innovative methods highlight the importance of research in medical advancements. His work exemplifies the potential of scientific innovation to improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…